tetano
Editor, Senior Moderator
Angiology
. 2023 Aug 19;33197231196175.
doi: 10.1177/00033197231196175. Online ahead of print. Cardiovascular and Venous Thromboembolic Events After Hospital Discharge for COVID-19: A Prospective Single Center Study
S Soudet[SUP] 1 2 [/SUP], D Basille[SUP] 3 4 [/SUP], H Carette[SUP] 3 [/SUP], M Mercier[SUP] 3 [/SUP], C Andrejak[SUP] 3 4 [/SUP], M-A Sevestre[SUP] 1 2 [/SUP]
Affiliations
Coronavirus disease 2019 (COVID-19) is associated with an increase in venous thrombotic and cardiovascular (CV) events has been reported during hospitalization. No systematic ultrasound follow-up to evaluate sequelae was ever that took place carried out prospectively associated with the evaluation of CV morbidity-mortality at 3 months post-discharge. Consecutive patients hospitalized for COVID-19 in the Amiens-Picardie University Hospital between 1[SUP]st[/SUP] February and 31[SUP]st[/SUP] August 2020 were included. The primary objective was the thrombosis incidence at 3 months after hospital discharge. Thrombosis was defined as either venous thromboembolism (VTE) or a CV event (CVE: myocardial infarction (MI), stroke or peripheral arterial disease). A secondary objective was to determine the risk factors for thrombotic events. We included 498 patients (279 men; 56%) of median age 66 (55-76) years. The primary composite outcome occurred in 27 patients (5.4%); 19 patients (3.8%) presented a CVE (stroke, n = 5; MI, n = 9; and peripheral arterial disease, n = 5). Two patients (0.8%) presented VTE. Six patients (1.2%) died. In multivariate analysis, a previous CVE was associated with thrombosis (OR 3.11; 95% CI 1.17-8.24). COVID-19 was significantly associated with thrombotic events post hospital discharge. Special attention should be given to CVE in the follow-up of patients with a previous thrombotic event.
Keywords: COVID-19; cardiovascular events; severe acute respiratory syndrome coronavirus2; venous thrombosis.
. 2023 Aug 19;33197231196175.
doi: 10.1177/00033197231196175. Online ahead of print. Cardiovascular and Venous Thromboembolic Events After Hospital Discharge for COVID-19: A Prospective Single Center Study
S Soudet[SUP] 1 2 [/SUP], D Basille[SUP] 3 4 [/SUP], H Carette[SUP] 3 [/SUP], M Mercier[SUP] 3 [/SUP], C Andrejak[SUP] 3 4 [/SUP], M-A Sevestre[SUP] 1 2 [/SUP]
Affiliations
- PMID: 37596862
- DOI: 10.1177/00033197231196175
Coronavirus disease 2019 (COVID-19) is associated with an increase in venous thrombotic and cardiovascular (CV) events has been reported during hospitalization. No systematic ultrasound follow-up to evaluate sequelae was ever that took place carried out prospectively associated with the evaluation of CV morbidity-mortality at 3 months post-discharge. Consecutive patients hospitalized for COVID-19 in the Amiens-Picardie University Hospital between 1[SUP]st[/SUP] February and 31[SUP]st[/SUP] August 2020 were included. The primary objective was the thrombosis incidence at 3 months after hospital discharge. Thrombosis was defined as either venous thromboembolism (VTE) or a CV event (CVE: myocardial infarction (MI), stroke or peripheral arterial disease). A secondary objective was to determine the risk factors for thrombotic events. We included 498 patients (279 men; 56%) of median age 66 (55-76) years. The primary composite outcome occurred in 27 patients (5.4%); 19 patients (3.8%) presented a CVE (stroke, n = 5; MI, n = 9; and peripheral arterial disease, n = 5). Two patients (0.8%) presented VTE. Six patients (1.2%) died. In multivariate analysis, a previous CVE was associated with thrombosis (OR 3.11; 95% CI 1.17-8.24). COVID-19 was significantly associated with thrombotic events post hospital discharge. Special attention should be given to CVE in the follow-up of patients with a previous thrombotic event.
Keywords: COVID-19; cardiovascular events; severe acute respiratory syndrome coronavirus2; venous thrombosis.